| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Picard Medical, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 31.07. | Picard Medical, Inc.: Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026 | 1 | GlobeNewswire (USA) | ||
| 27.07. | Picard Medical, Inc.: Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026 | 2 | GlobeNewswire (USA) | ||
| PICARD MEDICAL Aktie jetzt für 0€ handeln | |||||
| 27.07. | Picard Medical regains NYSE compliance | 2 | Seeking Alpha | ||
| 27.07. | Picard Medical regains compliance with NYSE American listing | 1 | Investing.com | ||
| 27.07. | Picard Medical, Inc.: Picard Medical Receives NYSE American Acceptance of Compliance Plan | 240 | GlobeNewswire (Europe) | TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first... ► Artikel lesen | |
| 22.07. | Picard Medical announces 1-for-50 reverse stock split to maintain NYSE American listing; stock slips | 3 | Seeking Alpha | ||
| 22.07. | Picard Medical approves 1-for-50 reverse stock split | 4 | Investing.com | ||
| 22.07. | Picard Medical, Inc.: Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance | 234 | GlobeNewswire (Europe) | -Reverse stock split to support continued compliance with NYSE American continued listing standards- TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the... ► Artikel lesen | |
| 21.07. | Picard Medical, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 15.07. | Picard Medical's artificial heart platform reviewed in journal | 2 | Investing.com | ||
| 15.07. | Fachzeitschrift beleuchtet Plattform für künstliches Herz von Picard Medical | 2 | Investing.com Deutsch | ||
| 15.07. | Picard Medical, Inc.: Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program | 139 | GlobeNewswire (Europe) | TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen | |
| 13.07. | Picard Medical, Inc.: Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting | 3 | GlobeNewswire (USA) | ||
| 02.07. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 02.07. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 02.07. | Picard Medical, Inc.: Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting | 1 | GlobeNewswire (USA) | ||
| 24.06. | Picard Medical CEO Patrick NJ Schnegelsberg to depart | 1 | MassDevice | ||
| 24.06. | Picard Medical CEO steps down, board names interim replacement | 2 | Investing.com | ||
| 24.06. | Picard Medical, Inc.: Picard Medical Announces Leadership Transition | 277 | GlobeNewswire (Europe) | TUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 24,440 | -1,13 % | Märkte am Morgen: Super Micro, Hims & Hers, Nebius, Thyssenkrupp Nucera, TUI | Der DAX erreichte am Dienstag erneut ein Rekordhoch bei rund 26.654 Punkten, schloss aber nur 0,26 Prozent höher. Vorbörslich zeichnet sich ein leicht schwächerer Start ab. Brent-Öl notiert knapp unter... ► Artikel lesen | |
| CERENOME | 2,665 | -1,11 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| ORGANON | 11,805 | -0,21 % | Dividendenbekanntmachungen (14.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADM HAMBURG AG DE0007269003 - 13,58 EUR AGCO CORPORATION US0010841023 0,3 USD 0,2602 EUR AGNT INC US30212W1009 0,05 USD 0,0433... ► Artikel lesen | |
| QUIDELORTHO | 12,490 | -0,87 % | QDEL's 2026 Outlook Cut Deepens China and Respiratory Risk Concerns | ||
| NANO-X IMAGING | 0,896 | -4,05 % | NANO-X IMAGING LTD: Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom | Initial three-year term includes minimum annual license commitments
PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. ("Nanox", or the "Company" NASDAQ: NNOX), a leader in innovative medical... ► Artikel lesen | |
| ROCKWELL MEDICAL | 7,260 | -3,01 % | Rockwell Medical steigert Umsatz um 11 %, verfehlt aber knapp die Analystenprognosen | ||
| NUWELLIS, INC | 1,220 | -3,17 % | Nuwellis, Inc. - 8-K, Current Report | ||
| INSPIREMD | 0,685 | -1,44 % | InspireMD signals potential FDA decisions in Q4 2026 while targeting $9M in annual cost savings | ||
| PROCEPT BIOROBOTICS | 21,770 | +3,22 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| NEURONETICS | 2,820 | -0,35 % | Neuronetics Reports Second Quarter 2026 Financial and Operating Results | MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health that combines its NeuroStar® TMS technology... ► Artikel lesen | |
| OPTIMIZERX | 8,520 | +0,35 % | OptimizeRx Corporation: OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth | The Company Names Andy D'Silva as the next Chief Financial Officer and Heather Favazza as Chief Accounting Officer effective January 1, 2027 Planned Transition Reflects Strong Succession Planning... ► Artikel lesen | |
| GLUCOTRACK | 0,340 | -0,58 % | Glucotrack regains Nasdaq compliance on equity requirement | ||
| BLUEJAY DIAGNOSTICS | 0,950 | -6,90 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and Commercialization | SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate... ► Artikel lesen | |
| PAVMED | 4,420 | +13,19 % | PAVmed Inc.: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results | Veris Health accelerated its commercial engagement with OSU-The James
Veris Health implantable physiological monitor achieved development milestones towards upcoming... ► Artikel lesen | |
| FEMASYS | 2,180 | +0,93 % | Femasys Inc.: Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update | -- $30 million financing enables execution of U.S. commercial strategy for the FemaSeed- fertility portfolio and advancement of the FemBloc- clinical and regulatory program toward U.S. approval... ► Artikel lesen |